TARSUS PHARMACEUTICALS INC's ticker is TARS and the CUSIP is 87650L103. A total of 157 filers reported holding TARSUS PHARMACEUTICALS INC in Q1 2024. The put-call ratio across all filers is 0.49 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $5,452 | – | 150,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,254,797 | $61,285,382 | 6.24% |
| Ikarian Capital, LLC | 800,277 | $21,751,529 | 3.79% |
| TFG Asset Management GP Ltd | 500,000 | $13,590,000 | 3.39% |
| Paradigm Biocapital Advisors LP | 2,435,416 | $66,194,607 | 2.53% |
| Frazier Life Sciences Management, L.P. | 1,587,527 | $43,148,984 | 2.02% |
| Ghost Tree Capital, LLC | 235,000 | $6,387,300 | 2.00% |
| COWEN AND COMPANY, LLC | 2,197,385 | $59,724,924 | 1.64% |
| TCG Crossover Management, LLC | 556,317 | $15,120,696 | 1.58% |
| Sands Capital Ventures, LLC | 170,000 | $4,620,600 | 1.55% |
| BOONE CAPITAL MANAGEMENT LLC | 216,047 | $5,872,157 | 1.53% |